Showing results (1181-1190 of 1,547) with videos related to
Sort By:
Pageof 155
Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade gliomaSteven Tobochnik, Michael S Regan, Maria K C Dorotan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.Neuro-Oncology|February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastasesTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.NPJ Breast Cancer|January 25, 2019
Assessment of <i>HMGA2</i> and <i>PLAG1</i> rearrangements in breast adenomyoepitheliomasFresia Pareja, Felipe C Geyer, David N Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced GliomaIngo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.Plos One|November 18, 2017
Radiographic prediction of meningioma grade by semantic and radiomic featuresThibaud P Coroller, Wenya Linda Bi, Elizabeth Huynh, et al.Neuro-Oncology|February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.Cancers|July 12, 2025
Prognostic Features of Recurrent Midline and H3 K27M-Mutant GliomaStephen J Bagley, Yoshie Umemura, Joe S Mendez, et al.Pageof 155